Alternative stents in ST-segment elevation myocardial infarction: improving the efficacy of primary percutaneous

Tuncay Yetgin1, Shimpei Nakatani1, Yoshinobu Onuma1

  • 11Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, 's-Gravendijkwal 230, 3015 GE Rotterdam, The Netherlands.

Future Cardiology
|May 30, 2015
PubMed

Insights

Primary percutaneous coronary intervention for ST-elevation myocardial infarction faces challenges. Novel stent designs aim to improve microvascular perfusion and long-term vessel health, enhancing clinical outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomaterials Science

Background:

  • Primary percutaneous coronary intervention (PCI) effectively restores epicardial blood flow in ST-elevation myocardial infarction (STEMI).
  • Impaired microvascular perfusion and long-term issues with permanent metallic stents limit PCI's full benefits and can lead to adverse clinical outcomes.
  • Distal embolization and stent malapposition are key challenges in primary PCI for STEMI.

Purpose of the Study:

  • To review novel stent designs aimed at optimizing mechanical reperfusion in primary PCI for STEMI.
  • To explore the role of innovative devices in overcoming limitations of current primary PCI strategies.
  • To assess improvements in microvascular perfusion and long-term vessel health offered by new stent technologies.

Main Methods:

  • Review of recent advancements in stent design for primary PCI.
  • Analysis of self-expanding stents, mesh-covered stents, and bioresorbable vascular scaffolds.
  • Evaluation of the impact of novel devices on microvascular function and biological response in STEMI patients.

Main Results:

  • New stent designs show promise in addressing microvascular dysfunction post-PCI.
  • Self-expanding, mesh-covered, and bioresorbable stents offer potential improvements over traditional metallic implants.
  • These innovations aim to mitigate issues like distal embolization and improve long-term vessel compatibility.

Conclusions:

  • Novel stent designs represent a significant advancement in managing STEMI.
  • These alternative devices have the potential to enhance reperfusion and improve patient outcomes in primary PCI.
  • Further research and clinical evaluation are warranted for these innovative interventional cardiology tools.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
606
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
487
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
421
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
783
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
439